Nutex Health, Inc. Income Statement

Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.17M0.87M1.78M1.59M1.46M1.07M0.47M-0.00M0.02M1.37M1.37M274.03M331.53M219.29M247.65M479.95M
Cost of Revenue 0.05M0.39M0.76M0.78M0.50M0.47M0.01M0.03M0.51M0.83M10.48M12.51M12.12M14.15M15.29M
Gross Profit 0.13M0.48M1.02M0.81M0.97M0.60M0.47M-0.01M0.86M0.54M157.61M179.28M15.42M34.77M196.26M
Operating items
Amortization - Intangibles 0.53M0.16M0.22M0.68M
Depreciation & Amortization - Total 596.000.00M0.01M0.01M0.00M662.00473.000.00M0.00M0.02M0.01M
Research & Development 0.60M0.55M0.77M0.56M0.29M
Selling, General & Administrative 0.81M1.83M1.86M2.38M1.69M0.72M0.53M0.45M1.81M0.95M3.67M4.43M5.46M19.81M33.23M41.92M
Restructuring Costs 3.60M3.90M0.04M
Other Operating Expenses -0.49M-2.94M0.21M2.98M-6.37M-12.35M14.20M14.20M241.76M
Operating Expenses 0.81M1.83M1.86M2.39M1.70M0.73M0.53M0.45M5.69M1.70M7.43M116.42M152.25M422.02M212.87M283.69M
Operating Income -0.68M-1.35M-0.84M-1.57M-0.73M-0.72M-0.53M-0.45M-5.69M-0.84M-6.90M153.17M170.26M-406.60M-31.77M130.70M
EBIT -0.68M-1.35M-0.84M-1.57M-0.73M-0.72M-0.53M-0.45M-5.69M-0.84M-6.90M153.17M170.26M-406.60M-31.77M130.70M
Non-operating items
Interest & Investment Income 0.00M0.01M0.03M0.01M114.0068.000.00M0.00M917.00
Other Non Operating Income -0.00M-0.31M-0.11M-0.22M-1.00M5.42M-0.56M-0.40M0.67M
Non Operating Income 0.03M0.04M0.66M0.08M-0.00M-0.00M-0.31M-0.11M0.10M18.95M21.50M30.92M30.40M31.15M
Net income details
EBT -0.68M-1.34M-0.82M-1.53M-0.07M-0.64M-0.54M-0.45M-6.06M-1.18M-7.12M145.74M169.49M-419.65M-48.49M109.83M
Tax Provisions -0.24M-0.50M-0.27M0.09M0.18M0.97M13.09M-5.07M15.02M
Profit After Tax 0.61M-0.84M-0.55M-1.62M0.25M-0.68M-0.54M-7.43M-6.01M-0.95M-7.12M145.56M168.53M-432.74M-45.79M94.81M
Income from Non-Controlling Interests 39.59M35.93M-7.96M2.36M42.71M
Income from Continuing Operations -0.44M-0.84M-0.55M-1.62M-0.07M-0.64M-0.54M-0.45M-6.06M-1.18M-7.12M145.56M168.53M-432.74M-43.42M94.81M
Consolidated Net Income -0.44M1.00M0.16M-1.62M0.32M-0.05M0.62M-6.98M6.59M-1.18M-7.12M-0.12M168.53M-432.74M-43.42M94.81M
Income towards Parent Company -0.44M1.00M0.16M-1.62M0.32M-0.05M0.62M-6.98M6.59M-1.18M-7.12M-0.12M168.53M-432.74M-43.42M94.81M
Net Income towards Common Stockholders -0.44M1.00M0.16M-1.62M0.32M-0.05M0.62M-6.98M6.59M-1.18M-7.12M98.89M119.76M-424.78M-45.79M52.18M
Additional items
EPS (Basic) -0.03-0.02-0.07-0.01-0.03-0.02-0.19-0.07-0.56-1.960.180.22-100.36-10.3910.23
EPS (Weighted Average and Diluted) -0.070.010.000.02-0.180.180.22-100.36-10.399.69
Shares Outstanding (Weighted Average) 0.32M4.33M4.47M5.44M
Shares Outstanding (Diluted Average) 23.96M25.99M25.95M29.17M39.69M
EBITDA -0.68M-1.34M-0.84M-1.56M-0.72M-0.72M-0.53M-0.45M-5.69M-0.84M-6.88M153.19M170.26M-406.60M-31.77M130.70M
Interest Expenses -0.05M-0.00M-0.00M0.00M0.37M0.34M0.63M6.43M6.20M12.49M16.32M19.93M
Tax Rate 35.04%37.28%32.92%0.12%0.57%10.45%13.68%